...

TriCore’s Chief Scientific Officer Named President-Elect of a National Association


10/09/2018

TriCore’s Chief Scientific Officer Named President-Elect of a National Association

For Immediate Release – October 9, 2018 (Albuquerque, New Mexico) - TriCore Reference Laboratories’ Chief Scientific Officer, Dr. David Grenache, has been named president-elect of the American Association for Clinical Chemistry (AACC) He was named president-elect starting in January 2019. Beginning in August 2020, he will serve a one-year term as president of the association.

The AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. The organization is recognized worldwide as an industry leader in education and advocacy, as well as a facilitator for collaboration within the laboratory community. Dr. Grenache has served in various leadership roles for AACC over the years, making him a natural choice to lead the organization. Of the appointment, Dr. Grenache said, “I’m excited and honored to serve as AACC’s president. I intend to use my experience, ideas, and enthusiasm to keep the association and its members at the forefront of laboratory medicine as well as be a strong proponent of encouraging new ways of advancing the practice and understanding of laboratory medicine in all clinical communities.”

"Dr. Grenache has made many contributions. One of those that has had lasting impact has been helping to create the framework for AACC’s Society for Young Clinical Laboratorians (SYCL)," Janet Kreizman, AACC’s CEO, wrote in an email. "SYCL provides AACC members who are under the age of 40 and/or trainees with the crucial professional development, networking and recognition opportunities."

Not only is this an important step for Dr. Grenache and TriCore, but for New Mexico, as well.  As President of AACC, Dr. Grenache will regularly engage in high-profile national and international conversations, bringing visibility to TriCore’s innovative work in New Mexico, demonstrating the laboratory’s unique value to positively impact patient care. Dr. David Grenache
-30-
TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide.  For more information, visit tricore.org.
 

TriCore in the News

Too few technologists: labs take inventive steps

The tight supply of technologists to fill open positions is pushing laboratories to be creative in finding answers. Memorial Sloan Kettering Cancer Center and TriCore Reference Laboratories found their answers by looking not just outward but also—and largely—inward.

CAP Today, April 2019,05/10/2019

Companies Focus on Helping Labs do More with Less

With no end in sight to the lab workforce shortage, vendors aim to fill the gap

AACC,04/09/2019

Practical challenges in peripheral blood smear evaluation

Unlike high-count monoclonal B-cell lymphocytosis, low-count MBL has a limited chance of progression to CLL and thus there is no need for follow-up. And a definitive diagnosis of T-cell large granulocytic leukemia requires demonstration of clonality. Those and other points were made in a CAP18 session on practical challenges in peripheral blood evaluation.

CAP Today,03/25/2019

Improving the Delivery of Healthcare through Clinical Diagnostic Insights: A Valuation of Laboratory Medicine through "Clinical Lab 2.0"

As healthcare payment and reimbursement begin to shift from a fee-for-service to a value-based model, ancillary providers including laboratories must incorporate this into their business strategy. Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation. Current literature in this area is limited.

Journal of Applied Laboratory Medicine,03/05/2019

Recent Tweets

Follow us on Twitter